Early research (Phase 1)Ended earlyNCT00006222What this trial is testingEMD 121974 in Treating Patients With HIV-Related Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00450320What this trial is testingSirolimus in Treating Patients With HIV-Related Kaposi's SarcomaWho this might be right forSarcoma AIDS Malignancy Consortium 7
Not applicableStudy completedNCT00096538What this trial is testingValganciclovir in Treating Patients With Classic Non-HIV-Associated Kaposi's SarcomaWho this might be right forSarcoma Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01057121What this trial is testingLenalidomide in Treating Patients With AIDS-Associated Kaposi's SarcomaWho this might be right forAIDS-Related Kaposi SarcomaRecurrent Kaposi Sarcoma National Cancer Institute (NCI) 38
Testing effectiveness (Phase 2)Study completedNCT00474994What this trial is testingSunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasWho this might be right forAdult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more Memorial Sloan Kettering Cancer Center 53
Early research (Phase 1)Study completedNCT01016730What this trial is testingBortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi SarcomaWho this might be right forAIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00090987What this trial is testingImatinib Mesylate in Treating Patients With HIV-Related Kaposi's SarcomaWho this might be right forSarcoma AIDS Malignancy Consortium 30
Testing effectiveness (Phase 2)Study completedNCT01154452What this trial is testingVismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaWho this might be right forAdult Alveolar Soft Part SarcomaAdult AngiosarcomaAdult Desmoplastic Small Round Cell Tumor+32 more National Cancer Institute (NCI) 78
Early research (Phase 1)Study completedNCT02595866What this trial is testingTesting the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and CancerWho this might be right forAIDS-Related Non-Hodgkin LymphomaClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+16 more National Cancer Institute (NCI) 58
Testing effectiveness (Phase 2)Study completedNCT00024024What this trial is testingBMS-275291 in Treating Patients With HIV-Related Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI) 59
Not applicableWithdrawnNCT00093678What this trial is testingCelecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerWho this might be right forCachexiaLymphomaMelanoma (Skin)+4 more Eastern Cooperative Oncology Group
Early research (Phase 1)Study completedNCT00003720What this trial is testingSU5416 in Treating Patients With AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma Pfizer
Early research (Phase 1)Ended earlyNCT00023790What this trial is testingPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the SkinWho this might be right forBreast CancerHead and Neck CancerLymphoma+3 more Case Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00020449What this trial is testingLiposomal Doxorubicin and Interleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00295984What this trial is testingNicotine Skin Patch in Treating Patients With Kaposi's SarcomaWho this might be right forSarcoma National Cancer Institute (NCI) 24